Search

Your search keyword '"F. Hoffmann-La Roche Ltd. -- Forecasts and trends -- Growth"' showing total 103 results

Search Constraints

Start Over You searched for: Descriptor "F. Hoffmann-La Roche Ltd. -- Forecasts and trends -- Growth" Remove constraint Descriptor: "F. Hoffmann-La Roche Ltd. -- Forecasts and trends -- Growth"
103 results on '"F. Hoffmann-La Roche Ltd. -- Forecasts and trends -- Growth"'

Search Results

1. Companion Diagnostics Market size is set to grow by USD 28.98 billion from 2024-2028, Rising use of personalized medicine to boost the market growth, Technavio

2. Oral Cancer Therapeutics Market size is set to grow by USD 1.61 billion from 2024-2028, Increasing incidence and prevalence of oral cancer to boost the market growth, Technavio

3. Digital Pathology Market size is set to grow by USD 1.12 billion from 2024-2028, Growing adoption of iot infrastructure among laboratories to boost the market growth, Technavio

4. Breast Cancer Therapeutics Market 2023, USD 15.64 billion Growth is Expected between 2023 to 2028, Robust pipeline and new drug approvals to Boost Growth - Technavio

5. Kidney Transplantation Therapeutics Market 2023; USD 643.15 million Growth Expected between 2023 and 2028, Rising prevalence of CKD and renal impairments to boost growth - Technavio

6. Hospital Infection Therapeutics Market is to grow by USD 3.10 billion, Special drug designations to boost growth - Technavio

7. Home Healthcare Market size to grow by USD 312.33 million from 2022 to 2027, North America to account for 44% of market growth - Technavio

8. Neurodiagnostics market size to grow by USD 4.04 billion from 2023 to 2028 | Europe to account for 36% of market growth - Technavio

9. Influenza Vaccine Market to grow by USD 2.93 billion from 2022 to 2027; North America to account for 54% of market growth - Technavio

10. Gonorrhea Therapeutics Market to grow by USD 506.68 million from 2022 to 2027; North America accounts for 39% of market growth - Technavio

11. Antibacterial Drugs Market to grow by USD 9.90 billion from 2022 to 2027 | Asia to account for 42% of market growth- Technavio

12. Medical Devices Market to grow by USD 177.95 billion from 2022 to 2027, North America to account for 39% of market growth- Technavio

13. Women's health diagnostics market to grow by USD 13.35 billion from 2022 to 2027, North America to account for 41% of market growth- Technavio

14. Endocrinology drugs market to grow by USD 36.55 billion from 2022 to 2027, North America to account for 45% of market growth- Technavio

15. Multiple Myeloma Drugs Market to grow by USD 6,419.94 million from 2022 to 2027|Growing incidence of multiple myeloma boosts the market growth - Technavio

16. Precision Medicine Market size to grow by USD 54.07 billion from 2022 to 2027|Growing prevalence of chronic diseases to boost market growth

17. Precision Medicine Market size to grow by USD 54.07 billion from 2022 to 2027|Growing prevalence of chronic diseases to boost market growth - Technavio

18. Ophthalmology therapeutics market size to increase by USD 15.72 billion from 2022 to 2027; North America will account for 44% of market growth

19. Digital pathology market size is to grow by USD 716.93 million from 2022 to 2027; 39% of the market growth to originate from North America - Technavio

20. Gene Therapy Market size is set to grow by USD 4,613.9 million from 2022 to 2027; Increase in special drug designations boosts the market growth - Technavio

21. Oncology market size in India to grow by USD 947.84 million between 2022 and 2027; Growth driven by increased prevalence of cancer - Technavio

22. Orphan drugs market to grow by USD 170.8 billion between 2022 and 2027; Growth driven by rising incidence of rare diseases - Technavio

23. Protein Therapeutics Market size to grow by USD 153.56 billion, the availability of favorable reimbursement policies to drive the market growth - Technavio

24. Idiopathic pulmonary fibrosis market size to grow by USD 1,360.99 million between 2022 and 2027; Growth driven by increasing prevalence of respiratory diseases - Technavio

25. Breast cancer therapeutics market size grow by USD 13.85 billion between 2021 to 2026; AbbVie Inc. and Amgen Inc., among others, emerge as key vendors - Technavio

26. Non-melanoma Skin Cancer Market size to grow at a CAGR of 5.76% from 2021 to 2026, Driven by the NMSC coverage and support - Technavio

27. Urticaria Drugs Market size to grow by USD 1.31 billion from 2021 to 2026, Driven by the growth in incidence of urticaria - Technavio

28. Non-hodgkin lymphoma therapeutics market size to increase by USD 5,427.51 million between 2022 and 2027; Growing awareness about cancer as a key trend - Technavio

29. Bacterial disease diagnostics market size to increase by USD 3,766.05 million between 2022 and 2027; Growth driven by high prevalence of infectious diseases - Technavio

30. Bacterial disease diagnostics market size to increase by USD 3,766.05 million between 2022 and 2027; Growth driven by high prevalence of infectious diseases - Technavio

31. Hospital Infection Therapeutics Market to grow at a CAGR of 4.98% from 2022 to 2027, antibiotics to be a major segment for the growth of the market - Technavio

32. Diffuse large B-cell lymphoma (DLBCL) therapeutics market size to increase by USD 2,061.88 million between 2022 and 2027; Growth driven by increasing approval of therapeutics - Technavio

33. In-vitro diagnostics instruments market size to increase by USD 48.3 billion between 2022 and 2027; Growth driven by growing geriatric population - Technavio

34. Personal emergency response system market size to grow at a CAGR of 7.94% by 2027; North America to account for 51% of market growth - Technavio

35. Cancer supportive care market to grow at a CAGR of 4.62% by 2027; North America to account for 39% of market growth - Technavio

36. Women's health therapeutics market size to increase by USD 30.35 billion: North America to account for 37% of market growth - Technavio

37. Retinal drugs market size to increase by USD 7.27579 billion; North America to account for 42% of market growth - Technavio

38. Ophthalmology therapeutics market size to increase by USD 15.72 billion: North America will account for 44% of market growth - Technavio

39. Hepatitis B and C diagnostics market size to increase by USD 2,055.79 million; North America to account for 47% of market growth - Technavio

40. Biosimilars market size to increase by USD 42,227.12 million: Europe to contribute 46% of market growth - Technavio

41. Endocrinology drugs market size to grow by USD 36551.24 Million: Increase in the incidence of endocrine disorders remains key growth driver - Technavio

42. Sexually transmitted disease (STD) testing market size to grow by USD 29,988.27 Million: Increasing prevalence of STDs remains key growth driver - Technavio

43. Biosimilars market size to increase by USD 42,227.12 million: Europe to contribute 46% of market growth - Technavio

44. Lung cancer therapeutics market size to grow by USD 10,204.33 million: High prevalence of lung cancer remains key growth driver - Technavio

45. Medical diagnostics market: Growth Opportunities led by 3M Co. and Abbott Laboratories - Technavio

46. Endocrinology drugs market size to grow by USD 36551.24 Million: Increase in the incidence of endocrine disorders remains key growth driver - Technavio

47. Sexually transmitted disease (STD) testing market size to grow by USD 29,988.27 Million: Increasing prevalence of STDs remains key growth driver - Technavio

48. Medical diagnostics market: Growth Opportunities led by 3M Co. and Abbott Laboratories - Technavio

49. HIV treatment drugs market in Africa: Growth Opportunities led by Abbott Laboratories and AbbVie Inc. - Technavio

50. In-vitro diagnostics instruments market: Growth Opportunities led by Abbott Laboratories and Beijing Leadman Biochemistry Technology Co. Ltd. - Technavio

Catalog

Books, media, physical & digital resources